Lurasidone
Imran Qureshi, PharmD, BCPP
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Schizophrenia in adults and adolescents (age 13-17)
- Bipolar I depression monotherapy in adults and pediatric patients (age 10-17)
- Bipolar I depression adjunct therapy to lithium or valproate in adult patients
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.